Search

everythinglearnresearchcommunity

for

Search:↓

Cholesterol sulfate buildup due to a genetic mutation disrupts the skin barrier, leading to the scaling skin seen in X-linked ichthyosis.

Dermatoscopy is a useful tool for diagnosing hair disorders and can help choose samples for more detailed analysis.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

DHT, a testosterone byproduct, causes male pattern baldness.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Zinc supplements can resolve skin issues caused by zinc deficiency.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

The review suggests younger men taking 1 mg finasteride report more side effects, including sexual, skin, metabolic, and psychological issues.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Finasteride doesn't affect bone density in male rats.

The normal human prostate does not significantly affect blood DHT levels.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Some skin problems can be signs of diabetes or other metabolic diseases and recognizing them can help diagnose and treat these diseases early.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Finasteride side effects in young men may be linked to specific gene variations.